During the past decade, Spec. Ophth. Hospital for Active Treatment- Academic Pashev conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 1 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 1 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Spec. Ophth. Hospital for Active Treatment- Academic Pashev" are "Diabetic Macular Edema" (2 trials). Many other conditions were trialed in "Spec. Ophth. Hospital for Active Treatment- Academic Pashev" in a lesser frequency.

Most popular intervention types in "Spec. Ophth. Hospital for Active Treatment- Academic Pashev" are "Drug" (2 trials), "Other" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Faricimab" (2 trials), "Sham Procedure" (2 trials) and "Aflibercept" (1 trials). Other intervention names were less common.

The vast majority of trials in "Spec. Ophth. Hospital for Active Treatment- Academic Pashev" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Spec. Ophth. Hospital for Active Treatment- Academic Pashev". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Spec. Ophth. Hospital for Active Treatment- Academic Pashev, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Spec. Ophth. Hospital for Active Treatment- Academic Pashev, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".